Given that CHIP in specific genes was significantly associated with current smoking status and acute exacerbation, CHIP can be considered as a candidate biomarker for COPD patients.
Keyphrases
- chronic obstructive pulmonary disease
- end stage renal disease
- respiratory failure
- high throughput
- ejection fraction
- chronic kidney disease
- newly diagnosed
- smoking cessation
- circulating tumor cells
- liver failure
- lung function
- genome wide
- patient reported outcomes
- transcription factor
- drug induced
- risk assessment
- cystic fibrosis
- single cell
- patient reported